Mark Lipsett

1.3k total citations
19 papers, 1.0k citations indexed

About

Mark Lipsett is a scholar working on Surgery, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mark Lipsett has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 11 papers in Genetics and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mark Lipsett's work include Pancreatic function and diabetes (15 papers), Diabetes and associated disorders (8 papers) and Diabetes Management and Research (6 papers). Mark Lipsett is often cited by papers focused on Pancreatic function and diabetes (15 papers), Diabetes and associated disorders (8 papers) and Diabetes Management and Research (6 papers). Mark Lipsett collaborates with scholars based in Canada and United States. Mark Lipsett's co-authors include Diane T. Finegood, D. Lynn Loriaux, Henry J. Ruder, Lawrence Rosenberg, Mauro Castellarin, Tatsuya Yoshimi, Lynn Rosenberg, Stephen Hanley, John J. Kopchick and Jun‐Li Liu and has published in prestigious journals such as Diabetes, Annals of Surgery and Diabetologia.

In The Last Decade

Mark Lipsett

18 papers receiving 977 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Lipsett Canada 16 620 483 476 281 127 19 1.0k
Diane Ostrega United States 16 847 1.4× 472 1.0× 490 1.0× 601 2.1× 147 1.2× 19 1.4k
Christopher Fink United States 11 779 1.3× 365 0.8× 367 0.8× 462 1.6× 125 1.0× 21 1.1k
Brenda Strutt Canada 17 663 1.1× 459 1.0× 421 0.9× 420 1.5× 149 1.2× 27 1.2k
Laurence E. Stout United States 14 376 0.6× 245 0.5× 213 0.4× 276 1.0× 52 0.4× 16 745
Kerstin Kirchhoff Germany 13 296 0.5× 235 0.5× 459 1.0× 369 1.3× 126 1.0× 14 1.0k
Manju Surana United States 14 664 1.1× 278 0.6× 370 0.8× 521 1.9× 133 1.0× 16 1.0k
Emanuel Gasser United States 8 330 0.5× 153 0.3× 184 0.4× 446 1.6× 148 1.2× 8 944
R V Rajotte Canada 11 571 0.9× 167 0.3× 357 0.8× 156 0.6× 44 0.3× 19 768
A A Like United States 15 740 1.2× 603 1.2× 877 1.8× 244 0.9× 186 1.5× 16 1.4k
B. Zabel Germany 13 166 0.3× 174 0.4× 249 0.5× 467 1.7× 55 0.4× 18 769

Countries citing papers authored by Mark Lipsett

Since Specialization
Citations

This map shows the geographic impact of Mark Lipsett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Lipsett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Lipsett more than expected).

Fields of papers citing papers by Mark Lipsett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Lipsett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Lipsett. The network helps show where Mark Lipsett may publish in the future.

Co-authorship network of co-authors of Mark Lipsett

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Lipsett. A scholar is included among the top collaborators of Mark Lipsett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Lipsett. Mark Lipsett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Potter, Kathryn J., Louise A. Scrocchi, Garth L. Warnock, et al.. (2009). Amyloid inhibitors enhance survival of cultured human islets. Biochimica et Biophysica Acta (BBA) - General Subjects. 1790(6). 566–574. 60 indexed citations
2.
Castellarin, Mauro, Maria Petropavlovskaia, Mark Lipsett, & Lawrence Rosenberg. (2007). The identification and sequence analysis of a new Reg3gamma and Reg2 in the Syrian golden hamster. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1769(9-10). 579–585. 7 indexed citations
3.
Lipsett, Mark, Stephen Hanley, Mauro Castellarin, et al.. (2007). The role of Islet Neogenesis-Associated Protein (INGAP) in islet neogenesis. Cell Biochemistry and Biophysics. 48(2-3). 127–137. 23 indexed citations
4.
Lipsett, Mark, Mauro Castellarin, & Lawrence Rosenberg. (2007). Acinar Plasticity. Pancreas. 34(4). 452–457. 27 indexed citations
5.
Aikin, Reid, Stephen Hanley, Dušica Maysinger, et al.. (2006). Autocrine insulin action activates Akt and increases survival of isolated human islets. Diabetologia. 49(12). 2900–2909. 35 indexed citations
6.
Lipsett, Mark, Emily Austin, Mauro Castellarin, Jean-François Lemay, & Lynn Rosenberg. (2006). Evidence for the homeostatic regulation of induced beta cell mass expansion. Diabetologia. 49(12). 2910–2919. 18 indexed citations
7.
Lipsett, Mark, et al.. (2006). Islet neogenesis: A potential therapeutic tool in type 1 diabetes. The International Journal of Biochemistry & Cell Biology. 38(5-6). 715–720. 18 indexed citations
8.
Hanley, Stephen, Shuqing Liu, Mark Lipsett, et al.. (2006). Tumor Necrosis Factor-α Production by Human Islets Leads to Postisolation Cell Death. Transplantation. 82(6). 813–818. 31 indexed citations
9.
Lipsett, Mark, et al.. (2005). Morphogenetic plasticity of adult human pancreatic islets of Langerhans. Cell Death and Differentiation. 12(7). 702–712. 66 indexed citations
10.
Lipsett, Mark, et al.. (2005). Islet neogenesis: A potential therapeutic tool in type 1 diabetes. The International Journal of Biochemistry & Cell Biology. 38(4). 498–503. 13 indexed citations
11.
Liu, Jun‐Li, Karen T. Coschigano, Mark Lipsett, et al.. (2004). Disruption of growth hormone receptor gene causes diminished pancreatic islet size and increased insulin sensitivity in mice. American Journal of Physiology-Endocrinology and Metabolism. 287(3). E405–E413. 178 indexed citations
12.
Rosenberg, Lawrence, Mark Lipsett, Ji‐Won Yoon, et al.. (2004). A Pentadecapeptide Fragment of Islet Neogenesis-Associated Protein Increases Beta-Cell Mass and Reverses Diabetes in C57BL/6J Mice. Annals of Surgery. 240(5). 875–884. 132 indexed citations
13.
Lipsett, Mark, Ali Hazrati, Steven Paraskevas, et al.. (2003). Signals for death and differentiation: a two-step mechanism for in vitro transformation of adult islets of Langerhans to duct epithelial structures. Cell Death and Differentiation. 10(9). 987–996. 24 indexed citations
14.
Rosenberg, Lawrence & Mark Lipsett. (2003). Biotherapeutic approaches to pancreatic cancer. Expert Opinion on Biological Therapy. 3(2). 319–337. 1 indexed citations
15.
Lipsett, Mark & Diane T. Finegood. (2002). β-Cell Neogenesis During Prolonged Hyperglycemia in Rats. Diabetes. 51(6). 1834–1841. 123 indexed citations
16.
Yuan, Songyang, et al.. (2002). Morphological and Functional Studies on Submucosal Islet Transplants in Normal and Diabetic Hamsters. Cell Transplantation. 11(6). 529–537. 20 indexed citations
17.
Tomita, Masako, George P. Chrousos, David D. Brandon, et al.. (1985). Glucocorticoid Receptors in Epstein-Barr Virus-Transformed Human Lymphocytes. Hormone and Metabolic Research. 17(12). 674–678. 21 indexed citations
18.
Loriaux, D. Lynn, Henry J. Ruder, & Mark Lipsett. (1971). The measurement of estrone sulfate in plasma. Steroids. 18(4). 463–472. 172 indexed citations
19.
Yoshimi, Tatsuya & Mark Lipsett. (1968). The measurement of plasma progesterone. Steroids. 11(4). 527–540. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026